Skip to search formSkip to main contentSkip to account menu

DDX53 gene

Known as: CAGE, CT26, cancer/testis antigen 26 
National Institutes of Health

Related topics

Related topics

1 relation
DDX52 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Remarkable apoptotic pathway of Hemiscorpius lepturus scorpion venom on CT26 cell line
Scorpion venom, considered as a treasure trove of various bioactive molecules, is a new approach to induce cancer cell death via… 
2018
2018
Role of DDX53 in taxol-resistance of cervix cancer cells in vitro.
2018
2018
Differential Regulation of T-cell mediated anti-tumor memory and cross-protection against the same tumor in lungs versus skin
ABSTRACT A major advantage of immunotherapy of cancer is that effector cells induced at one site should be able to kill… 
2011
2011
Correspondence Tumor Exosome-Mediated MDSC Activation
  • 2011
  • Corpus ID: 38787643
In a recent issue of The American Journal of Pathology, Xiang et al published their results concerning the effects of tumor… 
2009
2009
CAGE, a cancer/testis antigen, induces c-FLIPL and Snail to enhance cell motility and increase resistance to an anti-cancer drug
Cancer associated gene (CAGE) regulates expression of epithelial-mesenchymal transition (EMT)-related proteins through… 
2006
2006
Inhibition of murine K-BALB and CT26 tumour growth using a Semliki Forest virus vector with enhanced expression of IL-18.
The enhanced Semliki Forest virus vector (SFV10-E), an RNA-based suicide expression vector system, expresses foreign genes at… 
2006
2006
CAGE Displays Oncogenic Potential and Induces Cytolytic T Lymphocyte Activity
The cancer associated gene (CAGE) is a novel cancer/testis antigen. Over-expression of CAGE enhanced growth rates, promoted cell… 
2005
2005
Dendritic Cells Transduced with Tumor-Associated Antigen Gene Elicit Potent Therapeutic Antitumor Immunity: Comparison with Immunodominant Peptide-Pulsed DCs
Several studies have shown that vaccine therapy using dendritic cells (DCs) pulsed with specific tumor antigen peptides can… 
2003
2003
Synergistic Effect of a Granulocyte-Macrophage Colony-Stimulating Factor–Transduced Tumor Vaccine and Systemic Interleukin-2 in the Treatment of Murine Colorectal Cancer Hepatic Metastases
Background: Granulocyte-macrophage colony-stimulating factor–transduced tumor cell vaccines are less effective against cancer as… 
1999
1999
Antitumor Effects of Interleukin‐2 Gene‐modified Fibroblasts in an Orthotopic Colon Cancer Model
We transduced the interleukin‐2 (IL‐2) gene into murine fibroblasts BALBCL7 or murine colon cancer CT26 using a retroviral vector… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)